Business
In this episode, Paul Holmes talks to Silvia Taylor, SVP of corporate affairs at Novavax, and Adam Hildreth, founder/CEO of Crisp, about the reputation issues facing the pharmaceutical industry as the largest vaccine effort in the world rolls out to combat Covid-19. The group also addresses the disinformation Novavax had to deal with as part of their clinical trials and how the global pandemic has accelerated the urgency for transparency and humanity in healthcare communications.
More Episodes
Lenovo‘s Genevieve Hilton
2021-10-09
849
2021-10-09
849
Healthy Bites: The Future of Digital Health With Dan Carter
2021-09-29
791
2021-09-29
791
‘Back To Office‘ Plans Impact Diversity Initiatives
2021-09-21
814
2021-09-21
814
Healthy Bites: Data-Driven Communications With Emily Poe
2021-09-15
823
2021-09-15
823
Asian PR‘s creative evolution, with Ogilvy‘s Emily Poon
2021-09-13
826
2021-09-13
826
A Conversation With P&G On The Role And Risks Of Creativity
2021-09-09
797
2021-09-09
797
‘Relaunch Hong Kong‘ rumbles on
2021-09-09
737
2021-09-09
737
5 Reasons PR Should Be Involved In Lead Generation
2021-09-07
807
2021-09-07
807
Why It's Time For All PR Firms To Embrace Remote Work
2021-08-03
980
2021-08-03
980
The challenges of higher education communications
2021-07-28
920
2021-07-28
920
The evolution of public health communications
2021-07-26
813
2021-07-26
813
How Covid changed the creative process
2021-07-19
832
2021-07-19
832
The Role Of Communications In Techlash
2021-07-16
770
2021-07-16
770
Being Human In A Tech-Enabled World: Creativity
2021-07-07
788
2021-07-07
788
Creativity in PR 2021
2021-06-30
915
2021-06-30
915
The impact of fintech with Dan Simon
2021-06-28
731
2021-06-28
731
Get this podcast on your
phone, FREE
